DK0593339T3 - Fremgangsmåde til fremstilling af hepatitis A (HAV) antigen og vaccine - Google Patents

Fremgangsmåde til fremstilling af hepatitis A (HAV) antigen og vaccine

Info

Publication number
DK0593339T3
DK0593339T3 DK93402469T DK93402469T DK0593339T3 DK 0593339 T3 DK0593339 T3 DK 0593339T3 DK 93402469 T DK93402469 T DK 93402469T DK 93402469 T DK93402469 T DK 93402469T DK 0593339 T3 DK0593339 T3 DK 0593339T3
Authority
DK
Denmark
Prior art keywords
hav
vaccine
hepatitis
antigen
preparation
Prior art date
Application number
DK93402469T
Other languages
Danish (da)
English (en)
Inventor
Bernard Fanget
On Alain Fran
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Application granted granted Critical
Publication of DK0593339T3 publication Critical patent/DK0593339T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK93402469T 1992-10-14 1993-10-07 Fremgangsmåde til fremstilling af hepatitis A (HAV) antigen og vaccine DK0593339T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9212285A FR2696748B1 (fr) 1992-10-14 1992-10-14 Procédé de préparation d'antigènes et de vaccins de l'hépatite A (HAV).

Publications (1)

Publication Number Publication Date
DK0593339T3 true DK0593339T3 (da) 1999-11-08

Family

ID=9434534

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93402469T DK0593339T3 (da) 1992-10-14 1993-10-07 Fremgangsmåde til fremstilling af hepatitis A (HAV) antigen og vaccine

Country Status (10)

Country Link
US (1) US5731187A (ja)
EP (1) EP0593339B1 (ja)
JP (1) JP3724821B2 (ja)
AT (1) ATE179428T1 (ja)
CA (1) CA2108292C (ja)
DE (1) DE69324645T2 (ja)
DK (1) DK0593339T3 (ja)
ES (1) ES2132204T3 (ja)
FR (1) FR2696748B1 (ja)
GR (1) GR3030636T3 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018819A1 (en) * 1996-10-29 1998-05-07 Smithkline Beecham Biologicals S.A. Purification of respiratory syncytial virus antigens
US6261823B1 (en) 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
US6544769B1 (en) 1996-12-13 2003-04-08 Schering Corporation Compostions comprising viruses and methods for concentrating virus preparations
ES2283032T3 (es) * 1996-12-13 2007-10-16 Schering Corporation Metodos para purificar virus.
BR0309659A (pt) * 2002-04-30 2005-02-22 Oncolytics Biotech Inc Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso
WO2006011580A1 (ja) * 2004-07-27 2006-02-02 Genomidea, Inc. ウイルスエンベロープの精製方法
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
IL246769B (en) * 2015-07-23 2020-09-30 Grifols Sa Methods for the isolation of a virus produced in a test tube (in vitro) and the clearance of a virus
EP3695849A1 (en) 2019-02-13 2020-08-19 Mediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH Method for extracting hepatitis a virus (hav) antigen from cell culture
KR102277089B1 (ko) * 2019-12-19 2021-07-14 에스케이바이오사이언스(주) A형 간염 바이러스의 제조방법 및 상기의 방법에 따라 제조된 a형 간염 바이러스

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225583A (en) * 1987-08-06 1991-07-26 Merck & Co Inc Process for purifying hepatitis a virions (hav)
JPH0761955B2 (ja) * 1988-04-28 1995-07-05 国立予防衛生研究所長 凍結乾燥ａ型肝炎ワクチン
CA2047041A1 (en) * 1990-07-18 1992-01-19 John A. Lewis Process for purification of hepatitis-a virus capsids
IT1248075B (it) * 1991-06-18 1995-01-05 Sclavo Spa Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.

Also Published As

Publication number Publication date
FR2696748B1 (fr) 1994-12-30
DE69324645D1 (de) 1999-06-02
ES2132204T3 (es) 1999-08-16
JPH06279317A (ja) 1994-10-04
DE69324645T2 (de) 1999-12-30
CA2108292C (en) 2005-04-12
CA2108292A1 (en) 1994-04-15
US5731187A (en) 1998-03-24
EP0593339B1 (fr) 1999-04-28
JP3724821B2 (ja) 2005-12-07
FR2696748A1 (fr) 1994-04-15
EP0593339A1 (fr) 1994-04-20
GR3030636T3 (en) 1999-10-29
ATE179428T1 (de) 1999-05-15

Similar Documents

Publication Publication Date Title
WO1993000365A3 (en) Hepatitis c virus (hcv) polypeptides
DK643387D0 (da) T-celle-epitoper af hepatitis b-virus-nucleocapsid-protein
DK149397A (da) Fremgangsmåde til fremstilling af nitriloeddikesyrederivater
DK0593339T3 (da) Fremgangsmåde til fremstilling af hepatitis A (HAV) antigen og vaccine
DK166087A (da) Htlv-iii-virusprotein, dna-sekvens, der koder herfor, fremgangsmaade til fremstilling heraf, fremgangsmaade til detektion af aids-virus samt antistoffer mod aids-virus
DK437988D0 (da) Fremgangsmaade til rensning af hepatitis a vironer
NO863803L (no) Vaksiner og immunoanalyser for ervervet immunsviktsyndrom (aids).
DK383189D0 (da) Fremgangsmaade til mikrobiologisk fremstilling af humant serum albumin og lignende heterologe proteiner ved hjaelp af gaer
ATE81357T1 (de) Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
NZ222465A (en) Nanb (non a, non b hepatitis viral) antigen
ATE236262T1 (de) Rekombinanter schweinepocken-virus
ATE231557T1 (de) Detektion des hepatis-c virus.
DK0522291T3 (da) Fremgangsmåde til rensning af hepatitis A-virus (HAV), således renset virus og vaccinepræparater indeholdende dette
DE69433007D1 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
PH31116A (en) Methods for the treatment of infection caused by hepatitis B virus (hbv).
DK498387D0 (da) Virus-dna-sekvens
DK0716094T3 (da) Fremgangsmåde til oprensning af Hepatitis B-virus-overfladeantigen, som omfatter præS2-peptid
DE69225960D1 (de) Monoklonale antikörper gegen mögliche hcv-hüllregionen und methoden diese zu benutzen
IL76417A (en) Vaccine for hepatitis a virus based on strain hm-175
DK78990A (da) Fremgangsmaade til rensning af ydre membran protein for haemophilus influenza
ES550089A0 (es) Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.
FI952778A0 (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
FI943929A0 (fi) Hepatiitti C-viruspeptidejä
DE59907027D1 (de) Antivirale und antiretrovirale radioimmunpharmaka auf der basis von alpha- und beta-strahlern
DK379385A (da) Fremgangsmaade til paavisning af infektioes aids-virus